A CRISPR-Cas9 system for multiple genome editing and pathway assembly in Candida tropicalis

被引:28
|
作者
Zhang, Lihua [1 ,2 ]
Zhang, Haibing [1 ,2 ]
Liu, Yufei [2 ]
Zhou, Jingyu [1 ,2 ]
Shen, Wei [1 ,2 ]
Liu, Liming [1 ,3 ]
Li, Qi [1 ,2 ]
Chen, Xianzhong [1 ,2 ]
机构
[1] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Wuxi 214122, Jiangsu, Peoples R China
[2] Jiangnan Univ, Sch Biotechnol, Wuxi, Jiangsu, Peoples R China
[3] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China
关键词
Candida tropicalis; CRISPR-Cas9; genome editing; pathway assembly; yeast promoters; SACCHAROMYCES-CEREVISIAE; XYLITOL PRODUCTION; IN-VITRO; GENES; INTEGRATION; STRATEGY; EXPRESSION; STEP; VIVO; DNA;
D O I
10.1002/bit.27207
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Genetic manipulation is among the most important tools for synthetic biology; however, modifying multiple genes is extremely time-consuming and can sometimes be impossible when dealing with gene families. Here, we present a clustered regularly interspaced short palindromic repeat (CRISPR) and CRISPR-associated protein 9 (Cas9) system for use in the diploid yeast Candida tropicalis that is vastly superior to traditional techniques. This system enables the rapid and reliable introduction of multiple genetic deletions or mutations, as well as a stable expression using an integrated CRISPR-Cas9 cassette or a transient CRISPR-Cas9 cassette, together with a short donor DNA. We further show that the system can be used to promote the in vivo assembly of multiple DNA fragments and their stable integration into a target locus (or loci) in C. tropicalis. Based on this system, we present a platform for the biosynthesis of beta-carotene and its derivatives. These results enable the practical application of C. tropicalis and the application of the system to other organisms.
引用
收藏
页码:531 / 542
页数:12
相关论文
共 50 条
  • [31] CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia
    Chadwick, Alexandra C.
    Musunuru, Kiran
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (01) : 12 - 18
  • [32] Exploring the potential of genome editing CRISPR-Cas9 technology
    Singh, Vijai
    Braddick, Darren
    Dhar, Pawan Kumar
    GENE, 2017, 599 : 1 - 18
  • [33] Temperature effect on CRISPR-Cas9 mediated genome editing
    Xiang, Guanghai
    Zhang, Xingying
    An, Chenrui
    Cheng, Chen
    Wang, Haoyi
    JOURNAL OF GENETICS AND GENOMICS, 2017, 44 (04) : 199 - 205
  • [34] CRISPR-Cas9 MEDIATED GENOME EDITING IN ESCHERICHIA COLI
    Al-Wawi, M. Z.
    Hassan, R. M.
    Mohamed, M. E.
    Khan, M. F.
    Magaogao, M.
    Hossain, A.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2019, 10 (07): : 3373 - 3377
  • [35] CRISPR-Cas9: A revolution in genome editing in rheumatic diseases
    Duroux-Richard, Isabelle
    Giovannangeli, Carine
    Apparailly, Florence
    JOINT BONE SPINE, 2017, 84 (01) : 1 - 4
  • [36] Modern Prometheus Editing the Human Genome with CRISPR-CAS9
    Annas, George J.
    SCIENCE, 2016, 354 (6309) : 189 - 189
  • [37] Bioethical issues in genome editing by CRISPR-Cas9 technology
    Ayanoglu, Fatma Betul
    Elcin, Ayse Eser
    Elcin, Yasar Murat
    TURKISH JOURNAL OF BIOLOGY, 2020, 44 (02) : 110 - 120
  • [38] The Hope and Hype of CRISPR-Cas9 Genome Editing A Review
    Musunuru, Kiran
    JAMA CARDIOLOGY, 2017, 2 (08) : 914 - 919
  • [39] Genome characterization and CRISPR-Cas9 editing of a human neocentromere
    Antonio Palazzo
    Ilaria Piccolo
    Crescenzio Francesco Minervini
    Stefania Purgato
    Oronzo Capozzi
    Pietro D’Addabbo
    Cosimo Cumbo
    Francesco Albano
    Mariano Rocchi
    Claudia Rita Catacchio
    Chromosoma, 2022, 131 : 239 - 251
  • [40] Optimization of genome editing through CRISPR-Cas9 engineering
    Zhang, Jian-Hua
    Adikaram, Poorni
    Pandey, Mritunjay
    Genis, Allison
    Simonds, William F.
    BIOENGINEERED, 2016, 7 (03) : 166 - 174